Urinalysis Market

Urinalysis Market by Product (Dipsticks, Pregnancy & Fertility Kits, Reagents, Disposables, Automated, Semi-automated, POC Analyzers), Application (UTI, Diabetes, Kidney Diseases), End User (Hospitals, Labs, Homecare) & Test Type - Global Forecast to 2026

Report Code: MD 3259 Aug, 2021, by marketsandmarkets.com

[243 Pages Report] The global urinalysis market size is projected to reach USD 4.9 billion by 2026 from USD 3.5 billion in 2021, at a CAGR of 7.2%. Market growth is driven by the increasing burden of UTIs, diabetes, and kidney & liver diseases; rising geriatric population and the subsequent increase in age-associated diseases and increasing adoption of POC diagnostic tests.

Urinalysis Market

To know about the assumptions considered for the study, Request for Free Sample Report

COVID-19 Impact on Global Urinalysis Market

COVID-19 is an infectious disease caused by the most recently discovered novel coronavirus. Largely unknown before the outbreak began in Wuhan (China) in December 2019, COVID-19 moved from a regional crisis to a global pandemic in just a matter of a few weeks. The COVID-19 pandemic negatively affected the overall sales of most of the companies Lockdowns resulting from the COVID-19 pandemic caused people to delay undergoing health checkups, thus affecting the number of tests being performed and sales of reagents. However, a resurgence in testing numbers is seen as countries gradually ease restrictions on movement. According to National Kidney Foundation, people hospitalized with COVID-19 are at significant risk of (acute kidney injury) AKI, which can lead to serious illness, dialysis, and even death. The recovered COVID-19 patients who had an AKI or (acute renal failure) ARF are recommended to be seen regularly by a kidney doctor because their risk of developing chronic kidney disease is higher than others. COVID-19 patients who did not develop an AKI, but who had blood and/or protein in their urine, should be monitored since they are at increased risk of developing chronic- and end-stage kidney disease. With the COVID-19 pandemic, in addition to the development of vaccines and therapeutic drugs, there is a growing call for the development of more precise and simple testing technologies and the expansion of testing structures. COVID-19 has also impacted the regulatory environment and practices, as governments and healthcare providers face unprecedented challenges. Regulatory authorities utilized methods to speed approval of diagnostic products. Companies have taken strategic developments to introduce COVID-19 rapid tests, sustain their revenues, and nullify the impact of COVID-19 on their operational capabilities.

Market Dynamics

Driver: Rising geriatric population and the subsequent increase in age-associated diseases

The rising geriatric population in developed and developing regions will positively influence the growth of the urinalysis market. Due to rapid growth in the senior population, the prevalence of age-associated diseases such as diabetes, liver, and kidney diseases are expected to increase significantly. The diagnosis and management of such diseases are responsible for the increasing number of prescriptions for tests such as creatinine, albumin, glucose, ketones, and bilirubin, etc. These tests are performed by urinalysis; hence, it is expected to have a positive impact on this market.

Opportunity: Growth opportunities for urinalysis in growing economies

Developing economies such as India, South Korea, Brazil, and Mexico are expected to offer potential growth opportunities for major players operating in the urinalysis market. This can be attributed to the high disease prevalence, large patient population, improving healthcare infrastructure, increasing disposable income, and growing medical tourism in these countries. In addition to the factors mentioned above, the Asia Pacific has emerged as an adaptive and business-friendly hub due to relatively less stringent regulations and data requirements. Moreover, as markets in the US and Europe are maturing, most players are shifting their focus to emerging markets. The high investments in healthcare and life sciences research in emerging markets play an essential role in upgrading laboratory infrastructure in these countries. This, in turn, supports the installation of diagnostic systems in laboratories and leads to the growth of the urinalysis market.

Restraint: Unfavourable reimbursement scenario

The availability of refurbished instruments acts as a challenge in the growth of this market as these instruments offer the same functionalities as new equipment at a lower cost. Several end users, mainly small and medium-sized laboratories, opt for cost-effective and refurbished systems. In particular, the markets in developing countries, which are price-sensitive, prefer instruments that are cheap and offer similar functionalities. In the absence of well-grounded regulatory frameworks, there may be an influx of low-quality and refurbished products into the economy. Considering these factors, the demand for refurbished analyzers can be expected to increase in the coming years, as these systems offer the same functionalities at a lower cost. This is expected to hamper the revenue of companies offering branded analyzers, and thus restraining the overall growth of the market.

“In 2020, consumables segment accounted for the largest share of the urinalysis market, by product”

Based on product, the urinalysis market is segmented into consumables and instruments. In 2020, the consumables segment accounted for the largest share of this market. The frequent purchase of these products due to their recurrent usage drives the market growth of this segment.

“In 2020, disease screening segment accounted for the largest share in the market, by application”

The urinalysis market is segmented into disease screening and pregnancy and fertility. In 2020, the disease screening segment accounted for the largest share. This can be attributed to the increasing incidence of UTIs, diabetes, liver diseases and kidney ailments worldwide.

“North America is the largest regional market for the urinalysis”

The global urinalysis market is segmented into North America, Europe, Asia PacificRest of the World. In 2020, North America accounted for the largest share of the global urinalysis market. The North American urinalysis market's growth can be attributed to the growing geriatric population, implementation of favorable government initiatives, increasing healthcare expenditure, improved healthcare infrastructure, and the availability of technologically advanced instruments.

Urinalysis Market  by Region

To know about the assumptions considered for the study, download the pdf brochure

Some key players in the urinalysis market (2021- 2026)

  • Siemens Healthineers AG (Germany)
  • Roche Diagnostics Ltd. (Switzerland)
  • Cardinal Health Inc. (US)
  • Abbott Laboratories (US)
  • Danaher Corporation (US)

Scope of the Report

Report Metric

Details

Market size available for years

2019–2026

Base year considered

2020

Forecast period

2021–2026

Forecast units

Value (USD Billion)

Segments covered

Product, test type, application, end user, and region

Geographies covered

North America, Europe, Asia Pacific, and Rest of the World

Companies covered

Siemens Healthineers AG (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Cardinal Health, Inc. (US), Abbott Laboratories (US), Danaher Corporation (US), Sysmex Corporation (Japan), Quidel Corporation (US), Becton, Dickinson and Company (US), Bio-Rad Laboratories, Inc. (US), EKF Diagnostics (UK), Thermo Fisher Scientific Inc. (US), ARKRAY, Inc. (Japan), ACON Laboratories, Inc. (US), 77 Elektronika Kft. (Hungary), URIT Medical Electronic Group Co., Ltd. (China), Dirui Industrial Co., Ltd. (China), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), BIOBASE Group (China), ERBA Mannheim (UK), Alphatech Scientitfic (Peru), Teco Diagnostics (US), Analyticon Technologies AG (Germany), Bioway Biological Technology Co. Ltd. (China), High Technology Inc. (US) and Agappe Diagnostics Ltd. (India)

This report categorizes the urinalysis market into the following segments and subsegments:

By Product

  • Consumables
    • Pregnancy & Fertility Kits
    • Dipsticks
    • Disposables
    • Reagents
  • Instruments
    • Automated Urine Analyzers
      • Biochemical Urine Analyzers
        • Sediment Urine Analyzers
        • Microscopy Analyzers
      • Flow Cytometry Analyzers
      • Integrated Urine Analyzers
    • Semi-automated Urine Analyzers
    • Point-of-Care Urine Analyzers

By Test Type

  • Pregnancy & Fertility Tests
  • Biochemical Urinalysis
    • Laboratory Tests
    • POC Tests
  • Sediment Urinalysis

By Application

  • Disease Screening
    • Urinary Tract Infections
    • Kidney Diseases
    • Diabetes
    • Liver Diseases
    • Other Disease Screening Applications
  • Pregnancy and Fertility

By End User

  • Diagnostic Laboratories
  • Hospitals and Clinics
  • Home Care Settings
  • Research Laboratories & Institutes

By Region

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia Pacific
    • China
    • Japan
    • India
    • Rest of Asia Pacific (RoAPAC)
  • Rest of the World (RoW)

Recent Developments

  • In February 2021, 77 Elektronika Kft. (Hungary) launched LabStrip U mALB/CREA urine test strips.
  • In January 2021, ARKRAY, Inc. (Japan) launched AutionIDaten AE-4070 compact automated urine analyzer
  • In August 2020, Sysmex America, Inc. announced an exclusive agreement with Siemens Healthineers that granted North American rights to distribute and service Siemens Healthineers CLINITEK Novus Automated Urine Analyzer for hospital and reference laboratory use.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 31)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
           1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
           1.2.2 MARKETS COVERED
                    FIGURE 1 URINALYSIS MARKET SEGMENTATION
           1.2.3 YEARS CONSIDERED FOR THE STUDY
    1.3 CURRENCY
    1.4 LIMITATIONS
    1.5 STAKEHOLDERS
    1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 37)
    2.1 RESEARCH DATA
    2.2 RESEARCH APPROACH
           FIGURE 2 URINALYSIS MARKET: RESEARCH DESIGN
           2.2.1 SECONDARY DATA
                    2.2.1.1 Key data from secondary sources
           2.2.2 PRIMARY DATA
                    2.2.2.1 Key data from primary sources
                    2.2.2.2 Key industry insights
                               FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
    2.3 MARKET SIZE ESTIMATION
           2.3.1 BOTTOM-UP APPROACH
                    2.3.1.1 Approach 1: Company revenue estimation approach
                               FIGURE 4 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
                    2.3.1.2 Approach 2: Market estimation from the parent market
                               FIGURE 5 BOTTOM-UP APPROACH: MARKET ESTIMATION FROM THE PARENT MARKET
                    2.3.1.3 Approach 3: Presentations of companies and primary interviews
                    2.3.1.4 Growth rate assumptions
                    2.3.1.5 CAGR projections
                               FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
           2.3.2 TOP-DOWN APPROACH
                    FIGURE 7 URINALYSIS MARKET: TOP-DOWN APPROACH
    2.4 MARKET BREAKDOWN & DATA TRIANGULATION
           FIGURE 8 DATA TRIANGULATION METHODOLOGY
    2.5 ASSUMPTIONS FOR THE STUDY
    2.6 RISK ASSESSMENT
           TABLE 1 RISK ASSESSMENT: INFECTIOUS DISEASE DIAGNOSTICS MARKET
    2.7 COVID-19 HEALTH ASSESSMENT
    2.8 COVID-19 ECONOMIC ASSESSMENT
    2.9 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
           FIGURE 9 CRITERIA IMPACTING THE GLOBAL ECONOMY
           FIGURE 10 RECOVERY SCENARIO OF THE GLOBAL ECONOMY
    2.10 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE URINALYSIS MARKET

3 EXECUTIVE SUMMARY (Page No. - 50)
    FIGURE 11 URINALYSIS MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)
    FIGURE 12 URINALYSIS MARKET, BY TEST TYPE, 2021 VS. 2026 (USD MILLION)
    FIGURE 13 URINALYSIS MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
    FIGURE 14 URINALYSIS MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
    FIGURE 15 URINALYSIS MARKET, BY REGION, 2021 VS. 2026 (USD MILLION)

4 PREMIUM INSIGHTS (Page No. - 54)
    4.1 URINALYSIS MARKET OVERVIEW
           FIGURE 16 THE RISING ADOPTION OF POC DIAGNOSTICS IS A KEY FACTOR EXPECTED TO SUPPORT MARKET GROWTH DURING THE FORECAST PERIOD
    4.2 URINALYSIS MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)
           FIGURE 17 CONSUMABLES SEGMENT TO COMMAND THE LARGEST SHARE OF THE MARKET, BY PRODUCT, IN 2021
    4.3 URINALYSIS MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
           FIGURE 18 DISEASE SCREENING TO HOLD THE LARGEST SHARE OF THE MARKET DURING THE FORECAST PERIOD
    4.4 URINALYSIS MARKET, BY REGION, 2021 VS. 2026
           FIGURE 19 NORTH AMERICA TO DOMINATE THE MARKET IN 2021

5 MARKET OVERVIEW (Page No. - 57)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
           FIGURE 20 URINALYSIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Increasing burden of UTIs, diabetes, and liver & kidney diseases
                    5.2.1.2 Rising geriatric population and the subsequent increase in age-associated diseases
                               TABLE 2 ESTIMATED INCREASE IN THE GERIATRIC POPULATION BY REGION (2019-2050)
                    5.2.1.3 Increasing adoption of POC urine diagnostic tests
           5.2.2 RESTRAINTS
                    5.2.2.1 Availability of refurbished urine analyzers
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Emerging economies
                    5.2.3.2 Technological advancements in urine analyzers
           5.2.4 CHALLENGES
                    5.2.4.1 Changing regulatory landscape for the urinalysis market
    5.3 IMPACT OF COVID-19 ON THE URINALYSIS MARKET
    5.4 REALISTIC, PESSIMISTIC, AND OPTIMISTIC SCENARIOS
           5.4.1 URINALYSIS MARKET
                    FIGURE 21 REALISTIC SCENARIO
                    FIGURE 22 PESSIMISTIC SCENARIO
                    FIGURE 23 OPTIMISTIC SCENARIO
    5.5 PRICING ANALYSIS
           TABLE 3 PRICE OF URINALYSIS PRODUCTS (2021)
    5.6 PATENT ANALYSIS
           5.6.1 PATENT ANALYSIS OF URINALYSIS PRODUCTS
           5.6.2 PATENT ANALYSIS OF DIPSTICKS
    5.7 TRADE ANALYSIS
           5.7.1 TRADE ANALYSIS FOR DIAGNOSTIC AND LABORATORY REAGENTS
                    5.7.1.1 Import data for diagnostic and laboratory reagents, by country, 2016─2020 (USD Million)
                    5.7.1.2 Import data for diagnostic and laboratory reagents, by country, 2016─2020 (Tons)
    5.8 VALUE CHAIN ANALYSIS
           FIGURE 24 MAJOR VALUE IS ADDED DURING THE MANUFACTURING & ASSEMBLY PHASE
           FIGURE 25 DISTRIBUTION—A STRATEGY PREFERRED BY PROMINENT COMPANIES
    5.9 ECOSYSTEM ANALYSIS OF THE URINALYSIS MARKET
           FIGURE 26 URINALYSIS MARKET: ECOSYSTEM ANALYSIS
           5.9.1 ROLE IN ECOSYSTEM
    5.10 PORTER’S FIVE FORCES ANALYSIS
           TABLE 4 URINALYSIS MARKET: PORTER’S FIVE FORCES ANALYSIS
           5.10.1 THREAT OF NEW ENTRANTS
           5.10.2 THREAT OF SUBSTITUTES
           5.10.3 BARGAINING POWER OF BUYERS
           5.10.4 BARGAINING POWER OF SUPPLIERS
           5.10.5 DEGREE OF COMPETITION
    5.11 REGULATORY LANDSCAPE
           5.11.1 NORTH AMERICA
                    5.11.1.1 US
                    5.11.1.2 Canada
           5.11.2 EUROPE
           5.11.3 ASIA PACIFIC
                    5.11.3.1 China
                    5.11.3.2 Japan
                    5.11.3.3 India
           5.11.4 LATIN AMERICA
                    5.11.4.1 Brazil
                    5.11.4.2 MEXICO
           5.11.5 MIDDLE EAST
           5.11.6 AFRICA
    5.12 TECHNOLOGY ANALYSIS
    5.13 PESTLE ANALYSIS
    5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESSES
           5.14.1 REVENUE SHIFT & REVENUE POCKETS FOR URINALYSIS PRODUCT MANUFACTURERS
           5.14.2 REVENUE SHIFT FOR THE URINALYSIS MARKET

6 URINALYSIS MARKET, BY PRODUCT (Page No. - 77)
    6.1 INTRODUCTION
           TABLE 5 URINALYSIS MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
           TABLE 6 URINALYSIS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
    6.2 CONSUMABLES
           6.2.1 PRIMARY NOTES
                    6.2.1.1 Key industry insights
                               TABLE 7 URINALYSIS CONSUMABLES MARKET, BY TYPE, 2016–2019 (USD MILLION)
                               TABLE 8 URINALYSIS CONSUMABLES MARKET, BY TYPE, 2020–2026 (USD MILLION)
                               TABLE 9 URINALYSIS CONSUMABLES MARKET, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 10 URINALYSIS CONSUMABLES MARKET, BY REGION, 2020–2026 (USD MILLION)
           6.2.2 PREGNANCY & FERTILITY KITS
                    6.2.2.1 Need for rapid pregnancy testing to drive the growth of this market
                               TABLE 11 URINALYSIS PREGNANCY & FERTILITY KITS MARKET, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 12 URINALYSIS PREGNANCY & FERTILITY KITS MARKET, BY REGION, 2020–2026 (USD MILLION)
           6.2.3 DIPSTICKS
                    6.2.3.1 Dipsticks are used regularly owing to low costs and standard efficiency
                               TABLE 13 URINALYSIS DIPSTICKS MARKET, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 14 URINALYSIS DIPSTICKS MARKET, BY REGION, 2020–2026 (USD MILLION)
           6.2.4 DISPOSABLES
                    6.2.4.1 The wide usage of urine collection cups will drive the market demand for disposables
                               TABLE 15 URINALYSIS DISPOSABLES MARKET, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 16 URINALYSIS DISPOSABLES MARKET, BY REGION, 2020–2026 (USD MILLION)
           6.2.5 REAGENTS
                    6.2.5.1 Increasing use of controls & calibrators to drive the market growth for reagents
                               TABLE 17 URINALYSIS REAGENTS MARKET, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 18 URINALYSIS REAGENTS MARKET, BY REGION, 2020–2026 (USD MILLION)
    6.3 INSTRUMENTS
           TABLE 19 KEY PRODUCTS IN THE INSTRUMENTS MARKET
           TABLE 20 URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
           TABLE 21 URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2020–2026 (USD MILLION)
           TABLE 22 URINALYSIS INSTRUMENTS MARKET, BY REGION, 2016–2019 (USD MILLION)
           TABLE 23 URINALYSIS INSTRUMENTS MARKET, BY REGION, 2020–2026 (USD MILLION)
           6.3.1 AUTOMATED URINE ANALYZERS
                    6.3.1.1 Increasing need for automation for shorter turnaround times to drive the market growth for automated urine analyzers
                               TABLE 24 AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2016–2019 (USD MILLION)
                               TABLE 25 AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2026 (USD MILLION)
                               TABLE 26 AUTOMATED URINE ANALYZERS MARKET, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 27 AUTOMATED URINE ANALYZERS MARKET, BY REGION, 2020–2026 (USD MILLION)
                    6.3.1.2 Integrated urine analyzers
                               6.3.1.2.1 The higher workload in hospitals and laboratories to drive the adoption of integrated urine analyzers
                               TABLE 28 INTEGRATED URINE ANALYZERS MARKET, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 29 INTEGRATED URINE ANALYZERS MARKET, BY REGION, 2020–2026 (USD MILLION)
                    6.3.1.3 Sediment urine analyzers
                               6.3.1.3.1 Automated sediment urine analyzers increase the productivity of laboratories and integrate patient data for easy access
                               TABLE 30 SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2016–2019 (USD MILLION)
                               TABLE 31 SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2026 (USD MILLION)
                               TABLE 32 SEDIMENT URINE ANALYZERS MARKET, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 33 SEDIMENT URINE ANALYZERS MARKET, BY REGION, 2020–2026 (USD MILLION)
                               6.3.1.3.2 Microscopy analyzers
                                             6.3.1.3.2.1 Increased adoption of automated microscopy analyzers to drive the market growth of this segment
                               TABLE 34 MICROSCOPY ANALYZERS MARKET, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 35 MICROSCOPY ANALYZERS MARKET, BY REGION, 2020–2026 (USD MILLION)
                               6.3.1.3.3 Flow cytometry analyzers
                                             6.3.1.3.3.1 Accuracy and sensitivity of flow cytometry technique to drive the adoption of these analyzers
                               TABLE 36 FLOW CYTOMETRY ANALYZERS MARKET, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 37 FLOW CYTOMETRY ANALYZERS MARKET, BY REGION, 2020–2026 (USD MILLION)
                    6.3.1.4 Biochemical urine analyzers
                               6.3.1.4.1 Increasing incidence of kidney diseases & UTIs to increase the adoption of automated biochemical analyzers
                               TABLE 38 AUTOMATED BIOCHEMICAL URINE ANALYZERS MARKET, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 39 AUTOMATED BIOCHEMICAL URINE ANALYZERS MARKET, BY REGION, 2020–2026 (USD MILLION)
           6.3.2 SEMI-AUTOMATED URINE ANALYZERS
                    6.3.2.1 Semi-automated urine analyzers are used extensively in hospitals & clinics due to lower costs and practical efficiency
                               TABLE 40 SEMI-AUTOMATED ANALYZERS MARKET, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 41 SEMI-AUTOMATED URINE ANALYZERS MARKET, BY REGION, 2020–2026 (USD MILLION)
           6.3.3 POINT-OF-CARE URINE ANALYZERS
                    6.3.3.1 The need for rapid testing to drive the demand for POC urine analyzers
                               TABLE 42 POINT-OF-CARE URINE ANALYZERS MARKET, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 43 POINT-OF-CARE URINE ANALYZERS MARKET, BY REGION, 2020–2026 (USD MILLION)

7 URINALYSIS MARKET, BY TEST TYPE (Page No. - 96)
    7.1 INTRODUCTION
           TABLE 44 URINALYSIS MARKET, BY TEST TYPE, 2016–2019 (USD MILLION)
           TABLE 45 URINALYSIS MARKET, BY TEST TYPE, 2020–2026 (USD MILLION)
    7.2 PREGNANCY & FERTILITY TESTS
           7.2.1 RISING DEMAND FOR RAPID SELF-CONTAINED TESTS TO DRIVE THE GROWTH OF THIS SEGMENT
                    TABLE 46 PREGNANCY & FERTILITY TESTS MARKET, BY REGION, 2016–2019 (USD MILLION)
                    TABLE 47 PREGNANCY & FERTILITY TESTS MARKET, BY REGION, 2020–2026 (USD MILLION)
    7.3 BIOCHEMICAL URINALYSIS
           TABLE 48 BIOCHEMICAL URINALYSIS MARKET, BY TYPE, 2016–2019 (USD MILLION)
           TABLE 49 BIOCHEMICAL URINALYSIS MARKET, BY TYPE, 2020–2026 (USD MILLION)
           TABLE 50 BIOCHEMICAL URINALYSIS MARKET, BY REGION, 2016–2019 (USD MILLION)
           TABLE 51 BIOCHEMICAL URINALYSIS MARKET, BY REGION, 2020–2026 (USD MILLION)
           7.3.1 LABORATORY TESTS
                    7.3.1.1 Laboratory tests use automated or semi-automated analyzers
                               TABLE 52 BIOCHEMICAL URINALYSIS MARKET FOR LABORATORY TESTS, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 53 BIOCHEMICAL URINALYSIS MARKET FOR LABORATORY TESTS, BY REGION, 2020–2026 (USD MILLION)
           7.3.2 POC TESTS
                    7.3.2.1 The convenience of POC testing drives the growth of this segment
                               TABLE 54 BIOCHEMICAL URINALYSIS MARKET FOR POC TESTS, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 55 BIOCHEMICAL URINALYSIS MARKET FOR POC TESTS, BY REGION,  2020–2026 (USD MILLION)
    7.4 SEDIMENT URINALYSIS
           7.4.1 THE INCREASING ADOPTION OF AUTOMATED ANALYZERS TO DRIVE THE GROWTH OF THIS SEGMENT
                    TABLE 56 SEDIMENT URINALYSIS MARKET, BY REGION, 2016–2019 (USD MILLION)
                    TABLE 57 SEDIMENT URINALYSIS MARKET, BY REGION, 2020–2026 (USD MILLION)

8 URINALYSIS MARKET, BY APPLICATION (Page No. - 104)
    8.1 INTRODUCTION
           TABLE 58 URINALYSIS MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
           TABLE 59 URINALYSIS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
    8.2 DISEASE SCREENING
           TABLE 60 URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2016–2019 (USD MILLION)
           TABLE 61 URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2020–2026 (USD MILLION)
           TABLE 62 URINALYSIS MARKET FOR DISEASE SCREENING, BY REGION, 2016–2019 (USD MILLION)
           TABLE 63 URINALYSIS MARKET FOR DISEASE SCREENING, BY REGION, 2020–2026 (USD MILLION)
           8.2.1 URINARY TRACT INFECTIONS
                    8.2.1.1 Increasing prevalence of UTIs to drive the growth of this application segment
                               TABLE 64 URINALYSIS MARKET FOR URINARY TRACT INFECTIONS, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 65 URINALYSIS MARKET FOR URINARY TRACT INFECTIONS, BY REGION, 2020–2026 (USD MILLION)
           8.2.2 KIDNEY DISEASES
                    8.2.2.1 Rapidly growing geriatric population and the subsequent increase in the prevalence of kidney diseases to drive the market growth
                               TABLE 66 URINALYSIS MARKET FOR KIDNEY DISEASES, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 67 URINALYSIS MARKET FOR KIDNEY DISEASES, BY REGION, 2020–2026 (USD MILLION)
           8.2.3 DIABETES
                    8.2.3.1 Development of advanced analytical tools for diabetes to drive the market growth
                               TABLE 68 URINALYSIS MARKET FOR DIABETES, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 69 URINALYSIS MARKET FOR DIABETES, BY REGION, 2020–2026 (USD MILLION)
           8.2.4 LIVER DISEASES
                    8.2.4.1 The high prevalence of liver diseases increases the demand for urinalysis testing
                               TABLE 70 URINALYSIS MARKET FOR LIVER DISEASES, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 71 URINALYSIS MARKET FOR LIVER DISEASES, BY REGION, 2020–2026 (USD MILLION)
           8.2.5 OTHER DISEASE SCREENING APPLICATIONS
                    TABLE 72 URINALYSIS MARKET FOR OTHER DISEASE SCREENING APPLICATIONS, BY REGION, 2016–2019 (USD MILLION)
                    TABLE 73 URINALYSIS MARKET FOR OTHER DISEASE SCREENING APPLICATIONS, BY REGION, 2020–2026 (USD MILLION)
    8.3 PREGNANCY AND FERTILITY
           8.3.1 NEED FOR EARLY DETECTION OF PREGNANCY TO DRIVE THE GROWTH OF THIS APPLICATION SEGMENT
                    TABLE 74 URINALYSIS MARKET FOR PREGNANCY AND FERTILITY, BY REGION, 2016–2019 (USD MILLION)
                    TABLE 75 URINALYSIS MARKET FOR PREGNANCY AND FERTILITY, BY REGION, 2020–2026 (USD MILLION)

9 URINALYSIS MARKET, BY END USER (Page No. - 114)
    9.1 INTRODUCTION
           TABLE 76 URINALYSIS MARKET, BY END USER, 2016–2019 (USD MILLION)
           TABLE 77 URINALYSIS MARKET, BY END USER, 2020–2026 (USD MILLION)
           TABLE 78 URINALYSIS END USER MARKET, BY PRODUCT, 2018 (USD MILLION)
           TABLE 79 URINALYSIS END USER MARKET, BY APPLICATION, 2018 (USD MILLION)
           TABLE 80 URINALYSIS END USER MARKET, BY TEST TYPE, 2018 (USD MILLION)
    9.2 DIAGNOSTIC LABORATORIES
           9.2.1 INCREASING OUTSOURCING OF DIAGNOSTIC TESTS TO LABORATORIES FOR REDUCED COSTS DRIVES THE MARKET GROWTH
                    TABLE 81 URINALYSIS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2016–2019 (USD MILLION)
                    TABLE 82 URINALYSIS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2020–2026 (USD MILLION)
    9.3 HOSPITALS AND CLINICS
           9.3.1 THE INCREASING ADOPTION OF DIAGNOSTIC TOOLS FOR URINALYSIS TESTING TO DRIVE THE MARKET GROWTH FOR THIS END-USER SEGMENT
                    TABLE 83 URINALYSIS MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2016–2019 (USD MILLION)
                    TABLE 84 URINALYSIS MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2020–2026 (USD MILLION)
    9.4 HOME CARE SETTINGS
           9.4.1 INCREASING PREFERENCE FOR RAPID TESTING AND CONVENIENCE TO DRIVE THE GROWTH OF THIS MARKET
                    TABLE 85 URINALYSIS MARKET FOR HOME CARE SETTINGS, BY REGION, 2016–2019 (USD MILLION)
                    TABLE 86 URINALYSIS MARKET FOR HOME CARE SETTINGS, BY REGION, 2020–2026 (USD MILLION)
    9.5 RESEARCH LABORATORIES & INSTITUTES
           9.5.1 GROWING FOCUS ON DEVELOPING INNOVATIVE TESTS FOR DISEASE DETECTION TO DRIVE THE MARKET GROWTH
                    TABLE 87 URINALYSIS MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY REGION, 2016–2019 (USD MILLION)
                    TABLE 88 URINALYSIS MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY REGION, 2020–2026 (USD MILLION)

10 URINALYSIS MARKET, BY REGION (Page No. - 122)
     10.1 INTRODUCTION
               TABLE 89 URINALYSIS MARKET, BY REGION, 2016–2019 (USD MILLION)
               TABLE 90 URINALYSIS MARKET, BY REGION, 2020–2026 (USD MILLION)
     10.2 NORTH AMERICA
               FIGURE 27 NORTH AMERICA: URINALYSIS MARKET SNAPSHOT
               TABLE 91 NORTH AMERICA: URINALYSIS MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
               TABLE 92 NORTH AMERICA: URINALYSIS MARKET, BY COUNTRY, 2020–2026 (USD MILLION)
               TABLE 93 NORTH AMERICA: URINALYSIS MARKET, BY END USER, 2016–2019 (USD MILLION)
               TABLE 94 NORTH AMERICA: URINALYSIS MARKET, BY END USER, 2020–2026 (USD MILLION)
               TABLE 95 NORTH AMERICA: URINALYSIS END USER MARKET, BY PRODUCT, 2018 (USD MILLION)
               TABLE 96 NORTH AMERICA: URINALYSIS END USER MARKET, BY APPLICATION, 2018 (USD MILLION)
             10.2.1 US
                       10.2.1.1 The US dominated the North American urinalysis market in 2020
                                   TABLE 97 US: URINALYSIS MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
                                   TABLE 98 US: URINALYSIS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
                                   TABLE 99 US: URINALYSIS MARKET, BY TEST TYPE, 2016–2019 (USD MILLION)
                                   TABLE 100 US: URINALYSIS MARKET, BY TEST TYPE, 2020–2026 (USD MILLION)
                                   TABLE 101 US: URINALYSIS MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
                                   TABLE 102 US: URINALYSIS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
FALSE
                                   TABLE 104 US: URINALYSIS MARKET, BY END USER, 2020–2026 (USD MILLION)
             10.2.2 CANADA
                       10.2.2.1 The increasing prevalence of chronic conditions like liver diseases in Canada drives the market growth
                                   TABLE 105 CANADA: URINALYSIS MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
                                   TABLE 106 CANADA: URINALYSIS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
                                   TABLE 107 CANADA: URINALYSIS MARKET, BY TEST TYPE, 2016–2019 (USD MILLION)
                                   TABLE 108 CANADA: URINALYSIS MARKET, BY TEST TYPE, 2020–2026 (USD MILLION)
                                   TABLE 109 CANADA: URINALYSIS MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
                                   TABLE 110 CANADA: URINALYSIS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
                                   TABLE 111 CANADA: URINALYSIS MARKET, BY END USER, 2016–2019 (USD MILLION)
                                   TABLE 112 CANADA: URINALYSIS MARKET, BY END USER, 2020–2026 (USD MILLION)
     10.3 EUROPE
               TABLE 113 EUROPE: URINALYSIS MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
               TABLE 114 EUROPE: URINALYSIS MARKET, BY COUNTRY, 2020–2026 (USD MILLION)
               TABLE 115 EUROPE: URINALYSIS MARKET, BY END USER, 2016–2019 (USD MILLION)
               TABLE 116 EUROPE: URINALYSIS MARKET, BY END USER, 2020–2026 (USD MILLION)
               TABLE 117 EUROPE: URINALYSIS END USER MARKET, BY PRODUCT, 2018 (USD MILLION)
               TABLE 118 EUROPE: URINALYSIS END USER MARKET, BY APPLICATION, 2018 (USD MILLION)
             10.3.1 GERMANY
                       10.3.1.1 Increasing healthcare expenditure to drive the market growth in Germany
                                   TABLE 119 GERMANY: URINALYSIS MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
                                   TABLE 120 GERMANY: URINALYSIS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
                                   TABLE 121 GERMANY: URINALYSIS MARKET, BY TEST TYPE, 2016–2019 (USD MILLION)
                                   TABLE 122 GERMANY: URINALYSIS MARKET, BY TEST TYPE, 2020–2026 (USD MILLION)
                                   TABLE 123 GERMANY: URINALYSIS MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
                                   TABLE 124 GERMANY: URINALYSIS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
                                   TABLE 125 GERMANY: URINALYSIS MARKET, BY END USER, 2016–2019 (USD MILLION)
                                   TABLE 126 GERMANY: URINALYSIS MARKET, BY END USER, 2020–2026 (USD MILLION)
             10.3.2 UK
                       10.3.2.1 Rising government healthcare expenditure propels market growth in the UK
                                   TABLE 127 UK: URINALYSIS MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
                                   TABLE 128 UK: URINALYSIS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
                                   TABLE 129 UK: URINALYSIS MARKET, BY TEST TYPE, 2016–2019 (USD MILLION)
                                   TABLE 130 UK: URINALYSIS MARKET, BY TEST TYPE, 2020–2026 (USD MILLION)
                                   TABLE 131 UK: URINALYSIS MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
                                   TABLE 132 UK: URINALYSIS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
                                   TABLE 133 UK: URINALYSIS MARKET, BY END USER, 2016–2019 (USD MILLION)
                                   TABLE 134 UK: URINALYSIS MARKET, BY END USER, 2020–2026 (USD MILLION)
             10.3.3 FRANCE
                       10.3.3.1 Rising R&D expenditure in France to drive the market growth
                                   TABLE 135 FRANCE: URINALYSIS MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
                                   TABLE 136 FRANCE: URINALYSIS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
                                   TABLE 137 FRANCE: URINALYSIS MARKET, BY TEST TYPE, 2016–2019 (USD MILLION)
                                   TABLE 138 FRANCE: URINALYSIS MARKET, BY TEST TYPE, 2020–2026 (USD MILLION)
                                   TABLE 139 FRANCE: URINALYSIS MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
                                   TABLE 140 FRANCE: URINALYSIS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
                                   TABLE 141 FRANCE: URINALYSIS MARKET, BY END USER, 2016–2019 (USD MILLION)
                                   TABLE 142 FRANCE: URINALYSIS MARKET, BY END USER, 2020–2026 (USD MILLION)
             10.3.4 ITALY
                       10.3.4.1 Age-related chronic kidney disease owing to a large senior population in Italy to drive the market growth for urinalysis
                                   TABLE 143 ITALY: URINALYSIS MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
                                   TABLE 144 ITALY: URINALYSIS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
                                   TABLE 145 ITALY: URINALYSIS MARKET, BY TEST TYPE, 2016–2019 (USD MILLION)
                                   TABLE 146 ITALY: URINALYSIS MARKET, BY TEST TYPE, 2020–2026 (USD MILLION)
                                   TABLE 147 ITALY: URINALYSIS MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
                                   TABLE 148 ITALY: URINALYSIS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
                                   TABLE 149 ITALY: URINALYSIS MARKET, BY END USER, 2016–2019 (USD MILLION)
                                   TABLE 150 ITALY: URINALYSIS MARKET, BY END USER, 2020–2026 (USD MILLION)
             10.3.5 SPAIN
                       10.3.5.1 The rising geriatric population in Spain is expected to drive the market growth
                                   TABLE 151 SPAIN: URINALYSIS MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
                                   TABLE 152 SPAIN: URINALYSIS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
                                   TABLE 153 SPAIN: URINALYSIS MARKET, BY TEST TYPE, 2016–2019 (USD MILLION)
                                   TABLE 154 SPAIN: URINALYSIS MARKET, BY TEST TYPE, 2020–2026 (USD MILLION)
                                   TABLE 155 SPAIN: URINALYSIS MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
                                   TABLE 156 SPAIN: URINALYSIS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
                                   TABLE 157 SPAIN: URINALYSIS MARKET, BY END USER, 2016–2019 (USD MILLION)
                                   TABLE 158 SPAIN: URINALYSIS MARKET, BY END USER, 2020–2026 (USD MILLION)
             10.3.6 REST OF EUROPE
                       TABLE 159 ROE: URINALYSIS MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
                       TABLE 160 ROE: URINALYSIS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
                       TABLE 161 ROE: URINALYSIS MARKET, BY TEST TYPE, 2016–2019 (USD MILLION)
                       TABLE 162 ROE: URINALYSIS MARKET, BY TEST TYPE, 2020–2026 (USD MILLION)
                       TABLE 163 ROE: URINALYSIS MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
                       TABLE 164 ROE: URINALYSIS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
                       TABLE 165 ROE: URINALYSIS MARKET, BY END USER, 2016–2019 (USD MILLION)
                       TABLE 166 ROE: URINALYSIS MARKET, BY END USER, 2020–2026 (USD MILLION)
     10.4 ASIA PACIFIC
               FIGURE 28 APAC: URINALYSIS MARKET SNAPSHOT
               TABLE 167 APAC: URINALYSIS MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
               TABLE 168 APAC: URINALYSIS MARKET, BY COUNTRY, 2020–2026 (USD MILLION)
               TABLE 169 APAC: URINALYSIS MARKET, BY END USER, 2016–2019 (USD MILLION)
               TABLE 170 APAC: URINALYSIS MARKET, BY END USER, 2020–2026 (USD MILLION)
               TABLE 171 APAC: URINALYSIS END USER MARKET, BY PRODUCT, 2018 (USD MILLION)
               TABLE 172 APAC: URINALYSIS END USER MARKET, BY APPLICATION, 2018 (USD MILLION)
             10.4.1 CHINA
                       10.4.1.1 Improving healthcare infrastructure in China supports the growth of the urinalysis market
                                   TABLE 173 CHINA: URINALYSIS MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
                                   TABLE 174 CHINA: URINALYSIS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
                                   TABLE 175 CHINA: URINALYSIS MARKET, BY TEST TYPE, 2016–2019 (USD MILLION)
                                   TABLE 176 CHINA: URINALYSIS MARKET, BY TEST TYPE, 2020–2026 (USD MILLION)
                                   TABLE 177 CHINA: URINALYSIS MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
                                   TABLE 178 CHINA: URINALYSIS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
                                   TABLE 179 CHINA: URINALYSIS MARKET, BY END USER, 2016–2019 (USD MILLION)
                                   TABLE 180 CHINA: URINALYSIS MARKET, BY END USER, 2020–2026 (USD MILLION)
             10.4.2 INDIA
                       10.4.2.1 Increasing private & public investments in India’s healthcare system to drive the market growth for urinalysis testing
                                   TABLE 181 INDIA: URINALYSIS MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
                                   TABLE 182 INDIA: URINALYSIS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
                                   TABLE 183 INDIA: URINALYSIS MARKET, BY TEST TYPE, 2016–2019 (USD MILLION)
                                   TABLE 184 INDIA: URINALYSIS MARKET, BY TEST TYPE, 2020–2026 (USD MILLION)
                                   TABLE 185 INDIA: URINALYSIS MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
                                   TABLE 186 INDIA: URINALYSIS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
                                   TABLE 187 INDIA: URINALYSIS MARKET, BY END USER, 2016–2019 (USD MILLION)
                                   TABLE 188 INDIA: URINALYSIS MARKET, BY END USER, 2020–2026 (USD MILLION)
             10.4.3 JAPAN
                       10.4.3.1 Favorable regulatory framework to drive the market growth in Japan
                                   TABLE 189 JAPAN: URINALYSIS MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
                                   TABLE 190 JAPAN: URINALYSIS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
                                   TABLE 191 JAPAN: URINALYSIS MARKET, BY TEST TYPE, 2016–2019 (USD MILLION)
                                   TABLE 192 JAPAN: URINALYSIS MARKET, BY TEST TYPE, 2020–2026 (USD MILLION)
                                   TABLE 193 JAPAN: URINALYSIS MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
                                   TABLE 194 JAPAN: URINALYSIS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
                                   TABLE 195 JAPAN: URINALYSIS MARKET, BY END USER, 2016–2019 (USD MILLION)
                                   TABLE 196 JAPAN: URINALYSIS MARKET, BY END USER, 2020–2026 (USD MILLION)
             10.4.4 REST OF ASIA PACIFIC
                       TABLE 197 ROAPAC: URINALYSIS MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
                       TABLE 198 ROAPAC: URINALYSIS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
                       TABLE 199 ROAPAC: URINALYSIS MARKET, BY TEST TYPE, 2016–2019 (USD MILLION)
                       TABLE 200 ROAPAC: URINALYSIS MARKET, BY TEST TYPE, 2020–2026 (USD MILLION)
                       TABLE 201 ROAPAC: URINALYSIS MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
                       TABLE 202 ROAPAC: URINALYSIS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
                       TABLE 203 ROAPAC: URINALYSIS MARKET, BY END USER, 2016–2019 (USD MILLION)
                       TABLE 204 ROAPAC: URINALYSIS MARKET, BY END USER, 2020–2026 (USD MILLION)
     10.5 REST OF THE WORLD
             10.5.1 INCREASING GOVERNMENT INITIATIVES TO IMPROVE THE HEALTHCARE INFRASTRUCTURE IN THE REGION TO DRIVE THE MARKET GROWTH FOR URINALYSIS PRODUCTS
                       TABLE 205 ROW: URINALYSIS MARKET, BY END USER, 2016–2019 (USD MILLION)
                       TABLE 206 ROW: URINALYSIS MARKET, BY END USER, 2020–2026 (USD MILLION)
                       TABLE 207 ROW: URINALYSIS END USER MARKET, BY PRODUCT, 2018 (USD MILLION)
                       TABLE 208 ROW: URINALYSIS END USER MARKET, BY APPLICATION, 2018 (USD MILLION)

11 COMPETITIVE LANDSCAPE (Page No. - 169)
     11.1 OVERVIEW
     11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
             11.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN THE URINALYSIS MARKET
                       TABLE 209 OVERVIEW OF STRATEGIES DEPLOYED BY KEY URINALYSIS PRODUCT MANUFACTURING COMPANIES
     11.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
               FIGURE 29 REVENUE SHARE ANALYSIS OF THE TOP PLAYERS IN THE URINALYSIS MARKET
     11.4 MARKET SHARE ANALYSIS
               FIGURE 30 URINALYSIS MARKET SHARE, BY KEY PLAYER (2020)
               TABLE 210 URINALYSIS MARKET: DEGREE OF COMPETITION
             11.4.1 URINALYSIS MARKET RANKING, BY TEST TYPE
                       11.4.1.1 Biochemical urinalysis
                                   TABLE 211 GLOBAL BIOCHEMICAL URINALYSIS MARKET, BY KEY PLAYERS, 2020
                       11.4.1.2 Sediment urinalysis
                                   TABLE 212 GLOBAL SEDIMENT URINALYSIS MARKET, BY KEY PLAYERS, 2020
                       11.4.1.3 Pregnancy & fertility tests
                                   TABLE 213 GLOBAL PREGNANCY & FERTILITY TESTS MARKET, BY KEY PLAYERS, 2020
     11.5 COMPANY EVALUATION QUADRANT
             11.5.1 LIST OF EVALUATED VENDORS
             11.5.2 STARS
             11.5.3 EMERGING LEADERS
             11.5.4 PERVASIVE PLAYERS
             11.5.5 PARTICIPANTS
                       FIGURE 31 URINALYSIS MARKET: COMPETITIVE LEADERSHIP MAPPING, 2020
     11.6 COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS/SMES (2020)
             11.6.1 PROGRESSIVE COMPANIES
             11.6.2 STARTING BLOCKS
             11.6.3 RESPONSIVE COMPANIES
             11.6.4 DYNAMIC COMPANIES
                       FIGURE 32 URINALYSIS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS/SMES, 2020
     11.7 COMPETITIVE BENCHMARKING
               FIGURE 33 PRODUCT AND GEOGRAPHIC FOOTPRINT ANALYSIS OF TOP PLAYERS IN THE URINALYSIS MARKET
               TABLE 214 COMPANY PRODUCT TYPE FOOTPRINT
               TABLE 215 COMPANY GEOGRAPHICAL FOOTPRINT
     11.8 COMPETITIVE SCENARIO
             11.8.1 PRODUCT LAUNCHES AND REGULATORY APPROVALS
                       TABLE 216 KEY PRODUCT LAUNCHES AND REGULATORY APPROVALS
             11.8.2 DEALS
                       TABLE 217 KEY DEALS
             11.8.3 URINALYSIS: OTHER DEVELOPMENTS
                       TABLE 218 OTHER KEY DEVELOPMENTS

12 COMPANY PROFILES (Page No. - 180)
     12.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
             12.1.1 SIEMENS HEALTHINEERS AG
                       TABLE 219 SIEMENS HEALTHINEERS AG: BUSINESS OVERVIEW
                       FIGURE 34 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2020)
             12.1.2 F. HOFFMANN-LA ROCHE
                       TABLE 220 F. HOFFMANN-LA ROCHE: BUSINESS OVERVIEW
                       FIGURE 35 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2020)
             12.1.3 CARDINAL HEALTH, INC.
                       TABLE 221 CARDINAL HEALTH, INC.: BUSINESS OVERVIEW
                       FIGURE 36 CARDINAL HEALTH, INC.: COMPANY SNAPSHOT (2020)
             12.1.4 ABBOTT LABORATORIES
                       TABLE 222 ABBOTT LABORATORIES: BUSINESS OVERVIEW
                       FIGURE 37 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2020)
             12.1.5 DANAHER CORPORATION
                       TABLE 223 DANAHER CORPORATION: BUSINESS OVERVIEW
                       FIGURE 38 DANAHER CORPORATION: COMPANY SNAPSHOT (2020)
             12.1.6 SYSMEX CORPORATION
                       TABLE 224 SYSMEX CORPORATION: BUSINESS OVERVIEW
                       FIGURE 39 SYSMEX CORPORATION: COMPANY SNAPSHOT (2020)
             12.1.7 THERMO FISHER SCIENTIFIC INC.
                       TABLE 225 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW
                       FIGURE 40 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2020)
             12.1.8 QUIDEL CORPORATION
                       TABLE 226 QUIDEL CORPORATION: BUSINESS OVERVIEW
                       FIGURE 41 QUIDEL CORPORATION: COMPANY SNAPSHOT (2020)
             12.1.9 BECTON, DICKINSON AND COMPANY
                       TABLE 227 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
                       FIGURE 42 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2020)
             12.1.10 BIO-RAD LABORATORIES
                       TABLE 228 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
                       FIGURE 43 BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2020)
             12.1.11 EKF DIAGNOSTICS
                       TABLE 229 EKF DIAGNOSTICS: BUSINESS OVERVIEW
                       FIGURE 44 EKF DIAGNOSTICS: COMPANY SNAPSHOT (2020)
     12.2 OTHER PLAYERS
             12.2.1 ARKRAY, INC.
             12.2.2 ACON LABORATORIES, INC.
             12.2.3 77 ELEKTRONIKA KFT.
             12.2.4 URIT MEDICAL ELECTRONIC GROUP CO., LTD.
             12.2.5 DIRUI INDUSTRIAL CO., LTD.
             12.2.6 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
             12.2.7 BIOBASE GROUP
             12.2.8 ERBA MANNHEIM
             12.2.9 ALPHATECH SCIENTIFIC
             12.2.10 TECO DIAGNOSTICS
             12.2.11 ANALYTICON BIOTECHNOLOGIES AG
             12.2.12 BIOWAY BIOTECHNOLOGY
             12.2.13 HIGH TECHNOLOGY INC.
             12.2.14 AGAPPE DIAGNOSTICS LTD.
             12.2.15 GENRUI BIOTECH INC.
             12.2.16 SPINREACT S.A.
             12.2.17 DIALAB GMBH
             12.2.18 QUANTIMETRIX CORPORATION
             12.2.19 BIOCARE CORPORATION
             12.2.20 RANDOX LABORATORIES LTD.
             12.2.21 PZ CORMAY SA
             12.2.22 YD DIAGNOSTICS
             12.2.23 CONTEC MEDICAL SYSTEMS CO., LTD.
             12.2.24 RAYTO LIFE AND ANALYTICAL SCIENCES CO., LTD.

*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

13 APPENDIX (Page No. - 237)
     13.1 INSIGHTS FROM INDUSTRY EXPERTS
     13.2 DISCUSSION GUIDE
     13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     13.4 AVAILABLE CUSTOMIZATIONS
     13.5 RELATED REPORTS
     13.6 AUTHOR DETAILS

This study involved four major activities in estimating the current size of the urinalysis market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate segments and subsegments' market size.

Secondary Research

In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative and quantitative information as well as assess future prospects.

The following is a breakdown of the primary respondents:

Urinalysis Market  Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the urinalysis market's total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry have been identified through extensive secondary research
  • The revenues generated by leading players operating in the urinalysis market have been determined through primary and secondary research
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Global Urinalysis Market Size: Top-Down Approach

Urinalysis Market  Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Data Triangulation

After arriving at the overall market size applying the process mentioned above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Report Objectives

  • To define, describe, segment, and forecast the global urinalysis market by product, test type, application, end user, and region
  • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall urinalysis market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the market segments with respect to five regions, namely, North America, Europe, the Asia Pacific and Rest of the World
  • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
  • To track and analyze company developments such as product launches, agreements, expansions, and partnerships in the urinalysis market
  • To benchmark players within the market using the proprietary "Competitive Leadership Mapping" framework, which analyzes market players on various parameters within the broad categories of business and product strategy

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:

Country Information

  • Urinalysis market size and growth rate estimates for countries in the Rest of Europe, the Rest of Asia Pacific, and Rest of the World

Company profiles

  • Additional 12 company profiles of players operating in the urinalysis market.
COVID-19

Get in-depth analysis of the COVID-19 impact on the Urinalysis Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Urinalysis Market

Request For Special Pricing
Report Code
MD 3259
Published ON
Aug, 2021
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Urinalysis Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2021 MarketsandMarkets Research Private Ltd. All rights reserved